The multidisciplinary management of cholangiocarcinoma
Cancer · 15.01.2023 · 129 (2) · 184-214
DOI: 10.1002/cncr.34541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 16.11.2022. Verfasst von Kim C Ohaegbulam und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA. Hauptthemen laut MEDLINE: Bile Duct Neoplasms, Cholangiocarcinoma. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 292 Literaturangaben.
Abstract (Originalsprache)
Cholangiocarcinoma is a lethal malignancy of the biliary epithelium that can arise anywhere along the biliary tract. Surgical resection confers the greatest likelihood of long‐term survivability. However, its insidious onset, difficult diagnostics, and resultant advanced presentation render the majority of patients unresectable, highlighting the importance of early detection with novel biomarkers. Developing liver‐directed therapies and emerging targeted therapeutics may offer improved survivability for patients with unresectable or advanced disease. In this article, the authors review the current multidisciplinary standards of care in resectable and unresectable cholangiocarcinoma, with an emphasis on novel biomarkers for early detection and nonsurgical locoregional therapy options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Medicine, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Interventional Radiology, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon, USA.
- Department of Surgical Oncology, Oregon Health & Science University, Portland, Oregon, USA.
- Division of Hematology/Medical Oncology, Oregon Health & Science University, Portland, Oregon, USA.
- Division of Gastroenterology and Hepatology, Oregon Health & Science University, Portland, Oregon, USA.
ORCID-Profile: Kim C Ohaegbulam, Aaron J Grossberg
Zitieren
APA
Ohaegbulam, K. C., Koethe, Y., Fung, A., Mayo, S. C., Grossberg, A. J., Chen, E. Y., Sharzehi, K., Kardosh, A., Farsad, K., Rocha, F. G., Thomas, C. R., & Nabavizadeh, N. (2023). The multidisciplinary management of cholangiocarcinoma. Cancer, 129(2), 184-214. https://doi.org/10.1002/cncr.34541
Vancouver
Ohaegbulam KC, Koethe Y, Fung A, Mayo SC, Grossberg AJ, Chen EY, et al. The multidisciplinary management of cholangiocarcinoma. Cancer. 2023;129(2):184-214. doi:10.1002/cncr.34541
BibTeX
@article{Ohaegbulam2023,
author = {Ohaegbulam, Kim C and Koethe, Yilun and Fung, Alice and Mayo, Skye C and Grossberg, Aaron J and Chen, Emerson Y and Sharzehi, Kaveh and Kardosh, Adel and Farsad, Khashayar and Rocha, Flavio G and Thomas, Charles R and Nabavizadeh, Nima},
title = {The multidisciplinary management of cholangiocarcinoma},
journal = {Cancer},
year = {2023},
volume = {129},
number = {2},
pages = {184--214},
doi = {10.1002/cncr.34541}
}
EUVIMED